Article Text

Download PDFPDF

2022-RA-771-ESGO Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer
Free
  1. Martin Hruda,
  2. Helena Robová,
  3. Lukáš Rob,
  4. Michael Jiří Halaška,
  5. Jana Drozenová,
  6. Tomáš Pichlík and
  7. Hana Malíková
  1. Department of Obstetrics and Gynaecology, University Hospital Kralovske Vinohrady, Praha 10, Czech Republic

Abstract

Introduction/Background The standard procedure in cervical cancer is radical hysterectomy (RH) and pelvic lymphadenectomy (PLND). Because of the increasing age of women at childbirth, fertility becomes a major challenge. We present 20 years of experience with two-step less radical fertility-sparing surgery in women with IA1, LVSI positive, IA2 and IB1 (<2 cm, infiltration less than half of stromal invasions.

Methodology Preoperative workout consisted of histopathological diagnosis and magnetic resonance imaging along with ultrasonographic volumetry. We then performed laparoscopic sentinel lymph node mapping (SLNM) with frozen section (FS) followed by PLND and ‘selective parametrectomy’ (removal of afferent lymphatic channels from the paracervix) in case of a negative result. If verified by definitive histopathology, patients were treated by simple trachelectomy (IB1) or large cone (IA1/IA2) biopsy 1 week after primary surgery.

Results From 1999 to 2018, 91 women were enrolled in the study (median age 29.1 years, range 21–40). Of these 91 women, 51 (56.0%) were nulliparous. The detection rate of SLNs was 100% per patient and the specific side detection rate 96.7%. Positive lymph nodes were diagnosed in nine cases (9.8%). These women then underwent RH. Fertility was spared in 80 women but 4 recurred locally (5.0%). The mortality rate was 0.0%. The median follow-up was 149 months.

Conclusion Less radical fertility-sparing surgery with SLNM is safe in cervical cancers <2 cm at the largest diameter and infiltrating less than half of the cervical stroma. The recurrence rate is acceptable with no mortality. Morbidity with this procedure is low. Extended and accurate follow-up is necessary and human papillomavirus – high risk (HPV-HR tests seem to be useful in such follow-up assessment.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.